Health Care and Pharmaceutical (regulatory)


07 Apr: New appointments in Pavia e Ansaldo: Gabriele Girardello and Roberto Oliva promoted as partners

New appointments in Pavia e Ansaldo: Gabriele Girardello and Roberto Oliva promoted as partners   Milan, 7 April, 2022 – The Law firm Pavia e Ansaldo announces the promotion of the Counsels Gabriele Girardello and Roberto Oliva as Partners.   Both the lawyers operate in the Milan office of the Firm.   Gabriele Girardello carries out his activity in the context of the Departments of Industrial and Intellectual Property Law and Healthcare and Pharmaceutical. He has a consolidated litigation and extrajudicial experience, assisting domestic and international clients, in particular in the Life Sciences, manufacturing, Information Technology and fashion sectors. He…


26 Sep: Uso Compassionevole, Off Label e Off-Licence dei medicinali

Uso Compassionevole, Off Label e Off-Licence dei medicinali 26 September 2019 Crowne Plaza Milan City (Via Melchiorre Gioia, 73 – 20124, Milano)       PROGRAMMA: Uso compassionevole, Off-label e Off-licence dei medicinali   Speakers Dr.ssa Barbara Capaccetti, Country Medical Director Pfizer Avv. Agostino Migone de Amicis, Presidente, Comitato Etico Ist. Clinico Humanitas Avv. Claudia Pasturenzi, Studio Legale Astolfi e Associati, Milano Dr. Davide Tassinari, Direttore Unità Operativa Oncologia di Rimini


25 Mar: Life Sciences Practice Group – Annual Meeting

LIFE SCIENCES PRACTICE GROUP – ANNUAL MEETING   Program Monday, 25 March 2019 15,00 Inizio lavori 18,30 visita guidata in inglese alla Pietà Rondanini 19,30 Social Dinner Martedì 26 marzo   Panel 1 Status of EU and national legislation in view of the application (if and when) of Regulation 536/2014; impact of related Regulations, particularly GDPR Speakers: Dr. Liliana Burzilleri (Regione Lombardia) Dr. Felice Lopane (Assolombarda) Avv. Deborah Bolco (Pavia e Ansaldo) on GDPR aspects   Panel 2 Pprofit and non-profit approach in clinical trials in the new (Regulation or not) European environment, in the context of a continuing technological…


07 Feb: Veterinary medicines: the new EU Regulation is published

VETERINARY MEDICINES: THE NEW EU REGULATION IS PUBLISHED Milan, 7 February 2019 – After four years from the first regulation proposal on veterinary medicinal products (“VMP”)[1], on 26th November 2018 the Council approved the new Regulation, which has been published on the Official Journal on 7th January 2019 (EU Regulation 2019/6, the “Regulation”). The Regulation repeals Directive 2001/82/EC and shall apply from 28 January 2022. Since the first regulation proposal on this matter, the European Commission has called for an in-depth revision of the internal market of VMP. In particular, the Commission highlighted the need to harmonise the European legal framework,…


26 Oct: Pavia e Ansaldo sponsor of the 5th Healtcare Summit of Il Sole 24 Ore

PAVIA E ANSALDO SPONSOR OF THE 5TH HEALTHCARE SUMMIT OF IL SOLE 24 ORE “FUTURE HEALTHCARE” Agostino Migone De Amicis, partner of Pavia e Ansaldo, participated as speaker on “Research and independent experimentation: hub or … handicap for the development of Italian excellence?” Milan, 26 October 2016 – The 5th Healthcare Summit organized by Il Sole 24 Ore sponsored by, among others, Pavia e Ansaldo took place today in Rome. Agostino Migone De Amicis, partner and head of the Health and Pharmaceutical (Regulatory) Department of Pavia e Ansaldo as well as Chairman of the Ethics Committee of Humanitas, participated as speaker in…